Sort   by:  
 Page size 
GenomicsAutoanitbody Biomarkers for the Early Detection of Serous Ovarian Cancer
Autoanitbody Biomarkers for the Early Detection of Serous Ovarian Cancer
PRJNA316072 | ENA
ProteomicsAutoanitbody Biomarkers for the Early Detection of Serous Ovarian Cancer
Introduction: Serous ovarian cancer is the leading cause of gynecological cancers, with a 5-year survival rate below 45% due in part to the nonspecific symptoms and lack of accurate screening for early detection. In comparison, patients diagnosed at an early stage have a five-year survival rate of 9...
ORGANISM(S): Homo sapiens 
2017-06-01 | GSE79517 | GEO
ProteomicsAutoanitbody Biomarkers for the Early Detection of Serous Ovarian Cancer [Validation Screen]
Introduction: Serous ovarian cancer is the leading cause of gynecological cancers, with a 5-year survival rate below 45% due in part to the nonspecific symptoms and lack of accurate screening for early detection. In comparison, patients diagnosed at an early stage have a five-year survival rate of 9...
ORGANISM(S): Homo sapiens 
2017-06-01 | GSE79516 | GEO
ProteomicsAutoanitbody Biomarkers for the Early Detection of Serous Ovarian Cancer [Discovery Screen]
Introduction: Serous ovarian cancer is the leading cause of gynecological cancers, with a 5-year survival rate below 45% due in part to the nonspecific symptoms and lack of accurate screening for early detection. In comparison, patients diagnosed at an early stage have a five-year survival rate of 9...
ORGANISM(S): Homo sapiens 
2017-06-01 | GSE79498 | GEO
GenomicsHomo sapiens
Autoanitbody Biomarkers for the Early Detection of Serous Ovarian Cancer [Validation Screen]
PRJNA316074 | ENA
GenomicsHomo sapiens
Autoanitbody Biomarkers for the Early Detection of Serous Ovarian Cancer [Discovery Screen]
PRJNA315998 | ENA
ProteomicsData in support of Precision Proteomic Profiling of Systemic Lupus Erythematosus
In this study, we aimed to investigate the molecular basis for patient subtyping to form the basis for clinical differentiation of SLE patients with high versus low levels of C3dg as well as high versus low SLEDAI scores. Our study applied primarily applied a high-throughput LC-MS/MS method capable ...
ORGANISM(S): Homo sapiens (Human) 
2026-06-29 | PXD066214 | Pride
500spd Protein array Sle Autoanitbody 
Sort   by:  
 Page size